Vergleich

gdc-0834-s-enantiomer

ArtNr V4522-250mg
Hersteller InvivoChem LLC
CAS-Nr. 1133432-50-4
Menge 250 mg
Quantity options 100 mg 10 mg 25 mg 50 mg 5 mg
Kategorie
Typ Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Lieferbar
Description
InvivoChem Cat #:V4522CAS #:1133432-50-4Purity >=98%

Description: GDC-0834 S-enantiomer is the S-isomer of GDC-0834. GDC-0834 is a potent and selective BTK inhibitor. is a novel, potent and selective BTK inhibitor with an in vitro IC50 of 5.9 and 6.4 nM in biochemical and cellular assays, respectively, and in vivo IC50 of 1.1 and 5.6 uM in mouse and rat, respectively. Bruton's tyrosine kinase (BTK) plays a critical role in the development, differentiation, and proliferation of B-lineage cells, making it an attractive target for the treatment of rheumatoid arthritis. GDC-0834 inhibited BTK with an in vitro IC(50) of 5.9 and 6.4 nM in biochemical and cellular assays, respectively, and in vivo IC(50) of 1.1 and 5.6 uM in mouse and rat, respectively. Administration of GDC-0834 (30-100 mg/kg) in a rat collagen-induced arthritis (CIA) model resulted in a dose-dependent decrease of ankle swelling and reduction of morphologic pathology. An integrated disease progression pharmacokinetic/pharmacodynamic model where efficacy is driven by pBTK inhibition was fit to ankle-diameter time-course data. This model incorporated a transit model to characterize nondrug-related decreases in ankle swelling occurring at later stages of disease progression in CIA rats. The time course of ankle swelling in vehicle animals was described well by the base model. Simultaneous fitting of data from vehicle- and GDC-0834-treated groups showed that overall 73% inhibition of pBTK was needed to decrease the rate constant describing the ankle swelling increase (k(in)) by half. These findings suggest a high degree of pBTK inhibition is required for maximal activity of the pathway on inflammatory arthritis in rats.

References: 2011 Jul; 338(1):154-63; 2015 Jun; 43(6):908-15.

Related CAS: 1133432-50-4 (GDC-0834 S-enantiomer); 1133432-49-1 (GDC-0834 R-enantiomer); 1133432-46-8 (GDC-0834 Racemate)

GDC-0834 S-enantiomer

Name: GDC-0834
CAS#: 133432-46-8 (GDC-0834 Racemate); 1133432-49-1 (GDC-0834 R-enantiomer); 1133432-50-4 (GDC-0834 S-enantiomer)
Chemical Formula: C33H36N6O3S
Exact Mass: 596.25696
Molecular Weight: 596.74
Elemental Analysis: C, 66.42; H, 6.08; N, 14.08; O, 8.04; S, 5.37
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Technical Information
Synonym: GDC0834 S-enantiomer; GDC-0834 S-enantiomer; GDC 0834.
IUPAC/Chemical Name: (R)-N-(3-(6-((4-(1, 4-dimethyl-3-oxopiperazin-2-yl)phenyl)amino)-4-methyl-5-oxo-4, 5-dihydropyrazin-2-yl)-2-methylphenyl)-4, 5, 6, 7-tetrahydrobenzo[b]thiophene-2-carboxamide
InChi Key: CDOOFZZILLRUQH-GDLZYMKVSA-N
InChi Code: InChI=1S/C33H36N6O3S/c1-20-24(9-7-10-25(20)36-31(40)28-18-22-8-5-6-11-27(22)43-28)26-19-39(4)33(42)30(35-26)34-23-14-12-21(13-15-23)29-32(41)38(3)17-16-37(29)2/h7, 9-10, 12-15, 18-19, 29H, 5-6, 8, 11, 16-17H2, 1-4H3, (H, 34, 35)(H, 36, 40)/t29-/m1/s1
SMILES Code: O=C(C1=CC(CCCC2)=C2S1)NC3=CC=CC(C(N=C4NC5=CC=C([CH]6N(C)CCN(C)C6=O)C=C5)=CN(C)C4=O)=C3C

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 250 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen